Literature DB >> 32149471

Clinical and economic burden of wound care in the tropics: a 5-year institutional population health review.

Zhiwen J Lo1, Xuxin Lim1, Diane Eng2, Josip Car3, Qiantai Hong1, Enming Yong1, Li Zhang1, Sadhana Chandrasekar1, Glenn W L Tan1, Yam M Chan1, Seow C Sim1, Chien W Oei4, Xiaojin Zhang4, Ayliana Dharmawan4, Yi Z Ng5, Keith Harding5, Zee Upton5, Chun W Yap6, Bee H Heng6.   

Abstract

The aim of this study is to evaluate the clinical and economic burden of wound care in the Tropics via a 5-year institutional population health review. Within our data analysis, wounds are broadly classified into neuro-ischaemic ulcers (NIUs), venous leg ulcers (VLUs), pressure injuries (PIs), and surgical site infections (SSIs). Between 2013 and 2017, there were a total of 56 583 wound-related inpatient admissions for 41 461 patients, with a 95.1% increase in wound episodes per 1000 inpatient admissions over this period (142 and 277 wound episodes per 1000 inpatient admissions in 2013 and 2017, respectively). In 2017, the average length of stay for each wound episode was 17.7 days, which was 2.4 times that of an average acute admission at our institution. The average gross charge per wound episode was USD $12 967. Among the 12 218 patients with 16 674 wound episodes in 2017, 71.5% were more than 65 years of age with an average Charlson Comorbidity Index (CCI) of 7.2. Half (51.9%) were moderately or severely frail, while 41.3% had two or more wound-related admission episodes. In 2017, within our healthcare cluster, the gross healthcare costs for all inpatient wound episodes stand at USD $216 million within hospital care and USD $596 000 within primary care. Most NIU patients (97.2%) had diabetes and they had the most comorbidities (average CCI 8.4) and were the frailest group of patients (44.9% severely frail). The majority of the VLU disease burden was at the specialist outpatient setting, with the average 1-year VLU recurrence rate at 52.5% and median time between healing and recurrence at 9.5 months. PI patients were the oldest (86.5% more than 65 years-old), constituted the largest cohort of patients with 3874 patients at an incidence of 64.6 per 1000 admissions in 2017, and have a 1-year all-cause mortality rate of 14.3%. For SSI patients, there was a 125% increase of 14.2 SSI wound episodes per 1000 inpatient admissions in 2013 to 32.0 in 2017, and a 413% increase in wound-related 30-day re-admissions, from 40 in 2013 (4.1% of all surgeries) to 205 (8.3% of all surgeries) in 2017. The estimated gross healthcare cost per patient ranges from USD $15789-17 761 across the wound categories. Similar to global data, there is a significant and rising trend in the clinical and economic burden of wound care in Tropics.
© 2020 Medicalhelplines.com Inc and John Wiley & Sons Ltd.

Entities:  

Keywords:  chronic wounds; neuro-ischaemic ulcer; pressure injury; surgical site infection; venous leg ulcer

Mesh:

Year:  2020        PMID: 32149471     DOI: 10.1111/iwj.13333

Source DB:  PubMed          Journal:  Int Wound J        ISSN: 1742-4801            Impact factor:   3.315


  16 in total

1.  Wound assessment, imaging and monitoring systems in diabetic foot ulcers: A systematic review.

Authors:  Kai Siang Chan; Zhiwen Joseph Lo
Journal:  Int Wound J       Date:  2020-08-23       Impact factor: 3.315

2.  Outcomes of incisional negative pressure wound therapy following brachiobasilic transposition arteriovenous fistula creation: A 1:2 propensity score matched study.

Authors:  Kai Siang Chan; Muthaiah Arunaachalam; Qiantai Hong; En Ming Yong; Pravin Lingam; Li Zhang; Sadhana Chandrasekar; Glenn Wei Leong Tan; Zhiwen Joseph Lo
Journal:  Int Wound J       Date:  2020-04-29       Impact factor: 3.315

3.  Reply to: Observation on the article "More details are needed in calculating the burden of disease".

Authors:  Zhiwen Joseph Lo; Keith Harding; Josip Car
Journal:  Int Wound J       Date:  2020-05-07       Impact factor: 3.315

4.  More economic evaluations are needed in calculating the burden of wound care.

Authors:  Yi-Ping Song; Hong-Lin Chen
Journal:  Int Wound J       Date:  2020-04-29       Impact factor: 3.315

Review 5.  Application of chitosan-based nanoparticles in skin wound healing.

Authors:  Hooi Leong Loo; Bey Hing Goh; Learn-Han Lee; Lay Hong Chuah
Journal:  Asian J Pharm Sci       Date:  2022-04-25       Impact factor: 9.273

6.  Rationale for participation in venous leg ulcer clinical research: Patient interview study.

Authors:  Carolina D Weller; Catelyn Richards; Louise Turnour; Victoria Team
Journal:  Int Wound J       Date:  2020-07-13       Impact factor: 3.315

7.  Health-related quality of life and chronic wound characteristics among patients with chronic wounds treated in primary care: A cross-sectional study in Singapore.

Authors:  Xiaoli Zhu; Maja Magdalena Olsson; Ram Bajpai; Krister Järbrink; Wern Ee Tang; Josip Car
Journal:  Int Wound J       Date:  2021-12-02       Impact factor: 3.099

8.  Cohort study evaluating the burden of wounds to the UK's National Health Service in 2017/2018: update from 2012/2013.

Authors:  Julian F Guest; Graham W Fuller; Peter Vowden
Journal:  BMJ Open       Date:  2020-12-22       Impact factor: 2.692

9.  Clinical and economic outcomes of a multidisciplinary team approach in a lower extremity amputation prevention programme for diabetic foot ulcer care in an Asian population: A case-control study.

Authors:  Zhiwen Joseph Lo; Sadhana Chandrasekar; Enming Yong; Qiantai Hong; Li Zhang; Lester Rhan Chaen Chong; Glenn Tan; Yam Meng Chan; Hui Yan Koo; Tiffany Chew; Nur Faezah Sani; Keet Yeng Cheong; Leighton Ren Qin Cheng; Audrey Hui Min Tan; Sivakami Muthuveerappa; Tina Peiting Lai; Cheng Cheng Goh; Gary Y Ang; Zhecheng Zhu; Wai Han Hoi; Jaime H X Lin; Daniel E K Chew; Brenda Lim; Pei Shan Yeo; Huiling Liew
Journal:  Int Wound J       Date:  2021-08-06       Impact factor: 3.099

10.  Incidence of chronic wounds in Singapore, a multiethnic Asian country, between 2000 and 2017: a retrospective cohort study using a nationwide claims database.

Authors:  Orlanda Q Goh; Ganga Ganesan; Nicholas Graves; Yi Zhen Ng; Keith Harding; Kelvin Bryan Tan
Journal:  BMJ Open       Date:  2020-09-25       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.